Gene889
KRIT1: KRIT1 ankyrin repeat containing
Cite this record
ConductScience Library. KRIT1: KRIT1 ankyrin repeat containing. Genes, record 889. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/889
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O00522 | Krev interaction trapped protein 1 | 736 | 15 | Ensembl, GeneID, HGNC |
Source UniProt
Pathways106
The pathways and Gene Ontology terms that hold this gene, directly or through a sub-pathway or child term.
| Pathway or term | Source | Kind | Genes |
|---|---|---|---|
| integrin activation GO:0033622 | Gene Ontology | Biological process | 10 |
| regulation of establishment of cell polarity GO:2000114 | Gene Ontology | Biological process | 21 |
| regulation of establishment or maintenance of cell polarity GO:0032878 | Gene Ontology | Biological process | 24 |
| negative regulation of endothelial cell apoptotic process GO:2000352 | Gene Ontology | Biological process | 27 |
| anterior/posterior axis specification GO:0009948 | Gene Ontology | Biological process | 41 |
| negative regulation of endothelial cell proliferation GO:0001937 | Gene Ontology | Biological process | 41 |
| cell redox homeostasis GO:0045454 | Gene Ontology | Biological process | 43 |
| regulation of endothelial cell apoptotic process GO:2000351 | Gene Ontology | Biological process | 48 |
| negative regulation of endothelial cell migration GO:0010596 | Gene Ontology | Biological process | 54 |
| axis specification GO:0009798 | Gene Ontology | Biological process | 66 |
| endothelium development GO:0003158 | Gene Ontology | Biological process | 85 |
| phosphatidylinositol-4,5-bisphosphate binding GO:0005546 | Gene Ontology | Molecular function | 89 |
| negative regulation of epithelial cell proliferation GO:0050680 | Gene Ontology | Biological process | 91 |
| negative regulation of angiogenesis GO:0016525 | Gene Ontology | Biological process | 102 |
| anterior/posterior pattern specification GO:0009952 | Gene Ontology | Biological process | 103 |
| negative regulation of blood vessel morphogenesis GO:2000181 | Gene Ontology | Biological process | 103 |
| negative regulation of vasculature development GO:1901343 | Gene Ontology | Biological process | 104 |
| regulation of endothelial cell proliferation GO:0001936 | Gene Ontology | Biological process | 123 |
| phosphatidylinositol bisphosphate binding GO:1902936 | Gene Ontology | Molecular function | 128 |
| regulation of endothelial cell migration GO:0010594 | Gene Ontology | Biological process | 167 |
Pathways release pathways-2026-11-13-0.1.0
Patents202
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 50962 | O00522 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 6911 | O00522 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 6911 | O00522 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6911 | O00522 | Espacenet |
| US 20250074962 A1 | 2025-03-06 | 6765 | O00522 | Espacenet |
| US 20250074962 A1 | 2025-03-06 | 6767 | O00522 | Espacenet |
| US 20250074962 A1 | 2025-03-06 | 6768 | O00522 | Espacenet |
| US 20250074962 A1 | 2025-03-06 | 6769 | O00522 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 32735 | O00522 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 50962 | O00522 | Espacenet |
NIH grants519
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | KRIT1 papers | Newest fiscal year |
|---|---|---|---|
| T32HL007439 | Hematology Clinical Research Training Program | 7 | 2025 |
| R01NS121070 | Mechanisms of hypoxia induced exacerbation of cerebral cavernous malformations | 6 | 2025 |
| T32HD007009 | Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) | 6 | 2025 |
| T32HL007971 | Training grant in hemostasis and thrombosis | 6 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 5 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 4 | 2025 |
| R01GM102262 | LIM domain kinases: regulation and substrate recognition | 4 | 2025 |
| R25HL145817 | UCSD Future Faculty of Cardiovascular Sciences (FOCUS) | 3 | 2025 |
| U2CTR002818 | Data Management and Coordinating Center: Rare Diseases Clinical Research Network | 3 | 2025 |
Source NIH's project files
Papers1,075
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss-Of-Function CCM Gene Variants in Japanese Patients With Cerebral Cavernous Malformations. | Clin Genet | 2026 | 42785997 | PubTator, text mining | PubMed |
| Pediatric Familial Cerebral Cavernous Malformation Associated With a Novel KRIT1 Initiation-Region Frameshift Variant. | Mol Genet Genomic Med | 2026 | 42755143 | PubTator, text mining | PubMed |
| Intramedullary Spinal Cord Cavernous Angiomas in Familial Cerebral Cavernous Malformations. | Genes (Basel) | 2026 | 42650038 | PubTator, text mining | PubMed |
| Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein-protein interaction disruptors of the HEG1-KRIT1 interface. | J Comput Aided Mol Des | 2026 | 42611115 | PubTator, text mining | PubMed |
| Partial Oculomotor Nerve Palsy Revealing PDCD10-Related Familial Cerebral Cavernous Malformation in a Child. | Cureus | 2026 | 42495466 | PubTator, text mining | PubMed |
| Compound Danshen Dripping Pills retards the progression of cerebral cavernous malformations via strengthening vascular integrity and ameliorating inflammatory response. | Phytomedicine | 2026 | 42341528 | PubTator, text mining | PubMed |
| The skin as the mirror of the soul: familial multiple cavernous malformation syndrome in an infant with a ruptured intracranial cavernoma and multiple skin lesions. | Childs Nerv Syst | 2026 | 42262575 | PubTator, text mining | PubMed |
| kri-1/KRIT1 restrains skn-1/NRF2 activation to promote innate immune and lipid homeostasis. | bioRxiv | 2026 | 42239296 | PubTator, text mining | PubMed |
| Gene burden meta-analysis of 748 879 individuals identifies LGI1-ADAM23 protein complex association with epilepsy. | Epilepsia | 2026 | 42216960 | PubTator, text mining | PubMed |
| A Continuum of Atrial Peristalsis Initiates the Bicuspid to Quadricuspid Valve Transition. | bioRxiv | 2026 | 42146574 | PubTator, text mining | PubMed |
Expression109
This gene's TPM, transcripts per million, in Gene expression: up to six groups of each list, the highest median first.
Median TPM of KRIT1
TPM · Band: first to third quartile · Dot: median
By normal tissue · 6 of 51
By tumor and normal adjacent tissue · 6 of 57
By cell line · 1 of 1
| Group | Samples | Samples that pass QC | Median TPM | First quartile | Third quartile | Share with TPM of 1 or more |
|---|---|---|---|---|---|---|
| Thyroid | Normal tissue | 687 | 20 | 17.4 | 22.5 | 1 |
| Testis | Normal tissue | 410 | 19.9 | 17.1 | 22.4 | 1 |
| Cervix - Ectocervix | Normal tissue | 9 | 19.8 | 15.4 | 20.4 | 1 |
| Pituitary | Normal tissue | 300 | 19.7 | 16.7 | 22.4 | 1 |
| Cervix - Endocervix | Normal tissue | 10 | 19.1 | 17.3 | 20.8 | 1 |
| Ovary | Normal tissue | 195 | 17.8 | 15.5 | 19.6 | 1 |
| Acute Myeloid Leukemia | Tumor | 173 | 20.8 | 16.4 | 25.2 | 1 |
| Esophageal Carcinoma | Tumor | 184 | 14.7 | 10.6 | 20.2 | 1 |
| Testicular Germ Cell Tumors | Tumor | 156 | 14.6 | 10.6 | 19.7 | 1 |
| Glioblastoma Multiforme | Tumor | 155 | 14.6 | 11.5 | 19.4 | 1 |
| Lung Squamous Cell Carcinoma | Tumor | 503 | 13 | 9.6 | 16.9 | 1 |
| Brain Lower Grade Glioma | Tumor | 532 | 13 | 10.5 | 16.6 | 1 |
| K-562 | Cell line | 198 | 21.8 | 19.5 | 24.8 | 1 |
Gene expression release expression-atlas-2026-11-18-0.8.0
Gene expression so far: 43,590 genes, 8,834 studies and 359,840 samples, in release expression-atlas-2026-11-18-0.8.0. Its first release holds GTEx's 19,214 samples, TCGA's 11,348 and 7 SRA projects.
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0.
The results shown here are in whole or part based upon data generated by the TCGA Research Network. TCGA's samples and their metadata come through recount3 from NCI's Genomic Data Commons, https://gdc.cancer.gov, as open data under NIH's Genomic Data Sharing Policy.
recount3, Wilks and colleagues, Genome Biology 2021, https://doi.org/10.1186/s13059-021-02533-6.
The library is for research and education. It is not medical advice. Do not use it to diagnose or treat anyone. Library terms of use
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/889
GET https://conductscience.org/api/genes/v1/889/patents?page=2